Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
4 Wegovy pill offers a magnitude of weight loss that no other oral GLP-1 obesity candidate has been able to duplicate in phase 3 trials, boasting an average weight loss of about 17% (16.6%), when used along with a reduced calorie diet and exercise and if all patients stayed on treatment, compared to about 3% (2.7%) for placebo
It could be that because of the government shut-down, pharma companies will gain some extra days to respond to the warnings
People taking the GLP-1 pill may experience some of the most commonly reported side effects, such as: The Wegovy manufacturer also lists the following commonly reported side effects: headache fatigue dizziness bloating belching gas stomach flu heartburn runny nose sore throat low blood sugar in those with type 2 diabetes It notes that people will react differently to taking Wegovy and advises people to work with a healthcare professional to help them manage any side effects they experience
10.18565/cardio.2014.7.53-59 28
